Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-10-03
1988-06-07
Brown, J. R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514925, A61K 3702
Patent
active
047496835
ABSTRACT:
Secretion of gastric acid in the stomach of mammals is inhibited by parenteral administration of alpha-transforming growth factor.
REFERENCES:
Sachs, The New England Journal of Medicine, vol. 310, No. 12, Mar. 22, 1984, pp. 785-786.
Marquardt et al., PNAS U.S.A., vol. 80, Aug. 1983, pp. 4684-4688.
Sporn et al., Science, vol. 219, 1983, pp. 1329-1331.
Marquardt et al., cited in Chem. Abstracts, vol. 99, 1983, 116315e.
Murphy et al., Fed. Proc., 44(3), 1985, p. 441.
Delarco et al., Proc. Nat. Acad. Sci., vol. 75, pp. 4001-4005, (1978).
Marquardt et al., Science, vol. 223, pp. 1079-1082, (1984).
Bower et al., Experentia, vol. 31, 825-826, (1975).
Konturek et al., Gastroenterology, vol. 81, 438-443, (1981).
Tam et al., Nature, vol. 309, pp. 376-378, (1984).
Murphy Richard A.
Rhodes James A.
Brown J. R.
President and Fellows of Harvard College
Stone Jacqueline M.
LandOfFree
Inhibition of gastric acid secretion with alpha-transforming gro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of gastric acid secretion with alpha-transforming gro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of gastric acid secretion with alpha-transforming gro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-844903